Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v18-FR Version v17-EN
Language French English
Date Updated 2022-03-03 2022-03-03
Drug Identification Number 02230047 02230047
Brand name HYZAAR HYZAAR
Common or Proper name losartan potassium and hydrochlorothiazide tablets losartan potassium and hydrochlorothiazide tablets
Company Name ORGANON CANADA INC. ORGANON CANADA INC.
Ingredients HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM
Strength(s) 12.5MG 50MG 12.5MG 50MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 30 30
ATC code C09DA C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2022-01-28 2022-01-28
Actual start date 2022-01-24 2022-01-24
Estimated end date 2022-03-04 2022-03-04
Actual end date 2022-03-03 2022-03-03
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments